Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 6, Issue 11 (2017)

The role of tunnel revascularization on the periodontal tissues in elderly patients

Author(s):
Prots GB, Pyuryk VP, Turchyn RS, Prots II and Popovych AV
Abstract:
This article submissions examination and treatment of 30 persons aged 60-74 years with no signs of periodontal pathology and patients with chronic generalized periodontitis of II-III of the severity. For the purpose of comparative characteristics of treatments performed using X-rays, reoparodontography, ultrasound osteometric bone jaws, carried out the analysis of the functional state of the endothelium of vascular endothelial growth factor (VEGF), levels of tumor necrosis factor (TNF) and capillarization of periodontal tissues to treat and dynamics. All patients received the usual therapy of chronic generalized periodontitis, including closed curettage of periodontal pockets. 3 groups of patients on the background of basic therapy of periodontal handled tunnel revascularization with combined use of quercetin per os. It was established that with age in healthy elderly decrease in the number of functioning capillaries per unit area of fabric. The important role of the endothelium in providing compensatory angiogenesis in aging shows the relationship of vascular endothelial growth factor to the level of endothelium vasodilatation. Clinical determined that the combined use of revascularization tunnel and quercetin capillar stabilization drug in treatment of elderly patients with generalized periodontitis stimulates metabolism in periodontal tissues, stabilizes the clinical and radiological picture considerably prolongs remission.
Pages: 406-408  |  580 Views  8 Downloads
How to cite this article:
Prots GB, Pyuryk VP, Turchyn RS, Prots II, Popovych AV. The role of tunnel revascularization on the periodontal tissues in elderly patients. Pharma Innovation 2017;6(11):406-408.
The Pharma Innovation Journal